Crohn^s Disease
14 drugs49,783 FAERS reportsMedDRA PT
GET
/api/v1/reaction/crohn-s-diseaseReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D003424
A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.
Source: U.S. National Library of Medicine — MeSH (Crohn Disease)
Drugs reporting Crohn^s Disease (14)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Vedolizumab11,11113%
- 2Dibucaine1513%
- 3Azurite111%
- 4Cornsilk111%
- 5Xenon17.7%
- 6Isotretinoin2,8195.8%
- 7Ustekinumab5,7425.7%
- 8Mesalamine2,7795.1%
- 9Azathioprine4,3604.9%
- 10Colestipol993.9%
- 11Mercaptopurine5103.0%
- 12Adalimumab20,5572.9%
- 13Risankizumab1,7822.3%
- 14Fibrinogen61.9%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Colitis Ulcerative4 shared · 0.16
- Frequent Bowel Movements3 shared · 0.15
- Benign Neoplasm Of Thyroid Gland2 shared · 0.14
- Gambling2 shared · 0.14
- Metastasis2 shared · 0.14
- Major Depression2 shared · 0.13
- Intestinal Obstruction2 shared · 0.12
- Haemorrhoids2 shared · 0.11
- Squamous Cell Carcinoma Of Skin2 shared · 0.11
- Cardiomyopathy2 shared · 0.10
Literature
Recent PubMed references pinned to Crohn Disease as a MeSH major topic. About the reaction term itself — not about any specific drug.
- THE IMPACT OF OBESITY ON THE CLINICAL COURSE OF INFLAMMATORY BOWEL DISEASE.Arquivos de gastroenterologia · 2026 · Borsato ROR, Chebli JMF, Ribeiro TCDR, et al.PMID 42207082DOI 10.1590/S0004-2803.24612025-093
- Integrative Transcriptomic Analysis Identifies Shared Immune-Fibrotic Transcriptional Programs Across Crohn's Disease and Idiopathic Pulmonary Fibrosis.International journal of molecular sciences · 2026 · Luo R, Zhang Q, Fan Q, et al.PMID 42196408DOI 10.3390/ijms27104428
- Preliminary IL-1 Family Cytokine Signature for Crohn's Disease Onset in Pediatric Juvenile Idiopathic Arthritis.International journal of molecular sciences · 2026 · Polyanskaya AV, Soboleva AG, Mezentsev A, et al.PMID 42196228DOI 10.3390/ijms27104247
- Benefits of Surgical Management in Ileocecal Crohn's Disease: A Review of the Past Decade (2020-2026).Medicina (Kaunas, Lithuania) · 2026 · Balint I, Zaharie R, Dan V, et al.PMID 42195202DOI 10.3390/medicina62050949
- Biologic Therapy and Surgical Management in Crohn's Disease: Postoperative Outcomes and Biologic Management Patterns in a Retrospective Cohort Study.Medicina (Kaunas, Lithuania) · 2026 · Petraru CA, Stroie T, Istratescu D, et al.PMID 42195170DOI 10.3390/medicina62050917
- A Comparative Study of Different Biological Drugs in First-Line Therapy in Crohn's Disease: A Multicenter Descriptive Analysis.Medicina (Kaunas, Lithuania) · 2026 · Gila A, Preda CM, Diculescu M, et al.PMID 42195154DOI 10.3390/medicina62050901
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.